Oliphant et al developed simple clinical score to evaluate patients with Stage II colon cancer. These can help to identify patients who may benefit from more aggressive or novel therapies. The authors are from the University of Glasgow, the Glasgow Royal Infirmary and the West of Scotland Colorectal Cancer Managed Clinical Network.